Skip to main content
SpringerLink
Log in

ACE Inhibitors and Impotence: A Case Series from the Spanish Drug Monitoring System

  • Correspondence
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Frank GJ. The safety of ACE inhibitors for the treatment of hypertension and congestive heart failure. Cardiology 1989; 76: S56–67

    Article  Google Scholar 

  2. Breckenridge A. Age-related effects of converting enzyme inhibitors. J Cardiovasc Pharmacol 1988; 12: S100–4

    PubMed  Google Scholar 

  3. Burnier M, Waeber B, Nussberger J, et al. Effect of angiotensin converting enzyme inhibition in renovascular hypertension. J Hypertens 1989; 7: S27–31

    CAS  Google Scholar 

  4. Elliot HL. Antihypertensive drugs. In: Dukes MNG, editor. Meyler’s side effects of drugs. 12th ed. Amsterdam: Elsevier Science Publishers, 1992: 479–81

    Google Scholar 

  5. Laporte JR. Spain. In: Inman WH, editor. Monitoring for drug safety. 2nd ed. Lancaster: MTP Press Limited, 1986: 143–52

    Google Scholar 

  6. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181–4

    Article  PubMed  CAS  Google Scholar 

  7. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657–64

    Article  PubMed  CAS  Google Scholar 

  8. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981; 2: 539–43

    Google Scholar 

  9. Stessman J, Ben-Ishay D. Chlorthalidone-induced impotence. BMJ 1980; 281: 714

    Article  PubMed  CAS  Google Scholar 

  10. Miller RA. Propranolol and impotence. Ann Intern Med 1976; 85: 682–3

    PubMed  CAS  Google Scholar 

  11. Lundberg PO, Biriell C. Impotence — the drug risk factor. Int J Impotence Res 1993; 5: 237–9

    Google Scholar 

  12. Croog SH, Levine S, Sudilovski A, et al. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medication. Arch Intern Med 1988; 148: 788–94

    Article  PubMed  CAS  Google Scholar 

  13. The Treatment of Mild Hypertension Research Group. The treatment of mild hypertension study. A randomized, placebo-controlled trial of nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991; 151: 1413–23

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Regional de Farmacovigilancia de Castilla y León Faculty of Medicine, University of Valladolid, Valladolid, Spain

    Alfonso Carvajal, M. Teresa Lérida, Ana Sánchez, Luís H. Martín & Issac Martín de Diego

Authors
  1. Alfonso Carvajal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Teresa Lérida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ana Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luís H. Martín
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Issac Martín de Diego
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carvajal, A., Lérida, M.T., Sánchez, A. et al. ACE Inhibitors and Impotence: A Case Series from the Spanish Drug Monitoring System. Drug-Safety 13, 130–131 (1995). https://doi.org/10.2165/00002018-199513020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199513020-00007

Keywords

Search

Navigation